McKesson Records Show Failed Opioid Oversight, Lawsuit Says
- Shareholder claims board didn’t audit controls for painkillers
- Delaware judge unseals summary of confidential board minutes
How America's Opioid Crisis Spiraled Out of Control
This article is for subscribers only.
McKesson Corp.’s board failed to audit the company’s system to spot suspicious shipments of opioid-based painkillers even after agreeing to do so as part of a settlement, according to a summary of board minutes unsealed Friday in a shareholder lawsuit.
The suit, filed in October, alleges that McKesson directors paid scant attention to oversight of opioid sales after a 2008 settlement centering on the company’s insufficient monitoring of such shipments. The directors also disclaimed any responsibility for the growing opioid epidemic, seeing it as a “matter of public policy to be addressed by the federal and state governments,” the investor said in another unsealed portion of the complaint.